AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati — Cincinnati, Ohio

AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati is a clinical research site located in Cincinnati, Ohio, United States 45236-3669.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati has participated in 3 clinical trials.

Therapeutic areas: Respiratory Syncytial Virus, SARS-CoV-2, Influenza.

Sponsors: ModernaTX, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cincinnati

Browse all research sites in Ohio · View every site in Cincinnati

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati?

AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati conducted?

AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati has 3 clinical trials on record. Their work covers Respiratory Syncytial Virus, SARS-CoV-2, Influenza.

Is AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati accredited by Crixeo Clinical Trials?

AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.